The causes and clinical significance of fever in systemic lupus erythematosus: A retrospective study of 487 hospitalised patients

Lupus

Volumn 18, Issue 9, 2009, Pages 807-812

  Zhou, W J ^a   Yang, Cheng De ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Active; Fever; Infection; Steroid therapy; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C3; GLUCOCORTICOID; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID;

ADULT; ARTICLE; BRAIN DISEASE; DISEASE ACTIVITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG FEVER; DRUG MEGADOSE; FEMALE; FEVER; HEMOPHAGOCYTIC SYNDROME; HUMAN; INFECTION; LUPUS ENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SKIN INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX; URINARY TRACT INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; COMPLEMENT C3; FEMALE; FEVER; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS; NEOPLASMS; PREDNISONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS;

EID: 67650645772     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309103870     Document Type: Article

References (32)

1. Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 1964; 190: 104-111.
2. Yang CD, Wang XD, Ye S, et al. Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus. Clin Rheumatol 2007; 26: 895-901.
3. Qian J, Yang CD. Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: Two case reports and literature review. Clin Rheumatol 2007; 26: 807-810.
4. Stahl NI, Klippel JH, Decker JL. Fever in systemic lupus erythematosus. Am J Med 1979; 67: 935-940.
5. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
6. Ballestas HC. Postoperative fever: To what is the body really responding? AORN J 2007; 86: 983-988; quiz 989-992.
7. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992; 35: 630-640.
8. Rovin BH, Tang Y, Sun J, et al. Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int 2005; 68: 747-759.
9. Zonana-Nacach A, Camargo-Coronel A, Yanez P, et al. Infections in outpatients with systemic lupus erythematosus: A prospective study. Lupus 2001; 10: 505-510.
10. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-1754.
11. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
12. Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: Report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008; 15: 649-659.
13. Parker F. Examination of the skin and an approach to diagnosing skin diseases. In: Bennett JC, Plum F, (ed), Cecil textbook of medicine. Philadelphia: Saunders; 1996. p. 2190-2193.
14. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and latemanifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299-308.
15. Jallouli M, Frigui M, Marzouk S, et al. Infectious complications in systemic lupus erythematosus: A series of 146 patients. Rev Med Interne 2008; 29: 626-631.
16. Inoue T, Takeda T, Koda S, et al. Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis. Rheumatol Int 1986; 6: 69-77.
17. Bach JF. Infections and autoimmune diseases. J Autoimmun 2005; 25(Suppl.): 74-80.
18. Bosch X, Guilabert A, Pallares L, et al. Infections in systemic lupus erythematosus: A prospective and controlled study of 110 patients. Lupus 2006; 15: 584-589.
19. Massardo L, Martinez ME, Baro M, et al. Infections in systemic lupus erythematosus. Rev Med Chil 1991; 119: 1115-1122.
20. Oh HM, Chng HH, Boey ML, et al. Infections in systemic lupus erythematosus. Singapore Med J 1993; 34: 406-408.
21. Shyam C, Malaviya AN. Infection-related morbidity in systemic lupus erythematosus: A clinico-epidemiological study from northern India. Rheumatol Int 1996; 16: 1-3.
22. Gladman DD, Hussain F, Ibanez D, et al. The nature and outcome of infection in systemic lupus erythematosus. Lupus 2002; 11: 234-239.
23. Mok CC, Lau CS. Lupus in Hong Kong Chinese. Lupus 2003; 12: 717-722.
24. Al-Rayes H, Al-Swailem R, Arfin M, et al. Systemic lupus erythematosus and infections: A retrospective study in Saudis. Lupus 2007; 16: 755-763.
25. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003; 15: 528-534.
26. Mok MY, Lo Y, Chan TM, et al. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. J Rheumatol 2005; 32: 609-615.
27. Tam LS, Li EK, Wong SM, et al. Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol 2002; 31: 296-300.
28. Balakrishnan C, Mangat G, Mittal G, et al. Tuberculosis in patients with systemic lupus erythematosus. J Assoc Physicians India 1998; 46: 682-683.
29. Feng PH, Tan TH. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1982; 41: 11-14.
30. Victorio-Navarra ST, Dy EE, Arroyo CG, et al. Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 1996; 26: 628-634.
31. Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 1475-1482.
32. Noel V, Lortholary O, Casassus P, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001; 60: 1141-1144.